Skip to main content
Clinical Trials/IRCT20110226005914N3
IRCT20110226005914N3RecruitingPhase 2

Effects of melatonin on depression and cognition function in hemodialyzed patients, A randomized, double-blind, controlled trial

Oroumia University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
14 years to 70 years (—)
Sex
All

Inclusion Criteria

  • They should be hemodialized for at least 3 months and 3 times per week and 4 hours per visit.
  • They should be fluent in Farsi language .
  • They should have visual and auditory health to complete the questionnaire.

Exclusion Criteria

  • Have diabetes type 1 or 2.
  • Have psychotic disease
  • Take antidepressant medicationss.
  • Take anti-anxiety/sedative medications.

Investigators

Sponsor
Oroumia University of Medical Sciences

Similar Trials